Insight

Pharmaceutical Grade 4-Nitro-2,3-Lutidine-N-Oxide Coa Specs

Securing reliable supply chains for critical API intermediates often presents procurement teams with challenges regarding batch-to-batch variability and Certificate of Analysis verification delays.

Technical Specifications and Analytical Methods

Our pharmaceutical grade 4-Nitro-2,3-lutidine-N-oxide (CAS: 37699-43-7) is synthesized to meet rigorous industrial purity standards required for Lansoprazole production. Also known as 2,3-Dimethyl-4-nitropyridine N-Oxide, this pyridine N-oxide intermediate undergoes strict HPLC testing.

Parameter Specification Method
CAS Number 37699-43-7 -
Molecular Formula C7H8N2O3 -
Purity (HPLC) >98.0% HPLC
Appearance Yellow to Orange Solid Visual

Formulation Compatibility and Drop-in Replacement Advantages

Engineered as a seamless Lutidine N-oxide derivative, our product ensures stability in downstream reactions. For detailed insights into optimization, review our 2,3-Dimethyl-4-Nitropyridine N-Oxide Manufacturing Process Synthesis Route.

  • Consistent particle size distribution for improved solubility
  • Low heavy metal content suitable for sensitive catalytic steps
  • Validated stability profiles under standard storage conditions
  • Compatible with existing Lansoprazole synthesis workflows

Strict Quality Assurance Workflow and COA Verification

At NINGBO INNO PHARMCHEM CO.,LTD., every batch is accompanied by a comprehensive COA. Procurement officers can verify bulk price stability and quality metrics via our 4-Nitro-2,3-Lutidine-N-Oxide Bulk Price 2026 Global Manufacturer report.

Partner with a trusted global manufacturer for your API intermediate needs. We ensure consistent supply and documentation compliance at NINGBO INNO PHARMCHEM CO.,LTD.

For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.